Statutory health insurance-covered pre-exposure prophylaxis in Germany: changing trends in nationwide tenofovir disoproxil/emtricitabine prescriptions during the COVID-19 pandemic

Background: In 2019, Germany introduced a law to reimburse high-incidence populations for pre-exposure prophylaxis (PrEP), prescribed as tenofovir-disoproxil/emtricitabine (TDF/FTC), via statutory health insurance (SHI). We studied changes in TDF/FTC-prescriptions after the implementation of this la...

Descripción completa

Detalles Bibliográficos
Autores principales: Prins, Henrieke, Dörre, Achim, Schmidt, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10654745/
https://www.ncbi.nlm.nih.gov/pubmed/38026934
http://dx.doi.org/10.3389/fphar.2023.1241310

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10654745/
https://www.ncbi.nlm.nih.gov/pubmed/38026934
http://dx.doi.org/10.3389/fphar.2023.1241310

Ejemplares similares